Ortega-Joaquin N, Elías I, de la Cueva P, Del Pozo LJ, Boada A, Moreno D, Aguilar M, Mosquera E, Mirada A, Gibbons C, Oyagüez I
Cost-effectiveness of ingenol mebutate versus imiquimod 5% for actinic keratosis treatment in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Elias I, Ortega-Joaquin N, Aguilar M, Moreno D, Boada A, Del Pozo LJ, De la Cueva P, Mirada A, Mosquera E, Gibbons C, Oyagüez I
Cost-utility analysis of ingenol mebutate versus diclofenac 3% for actinic keratosis treatment in Spain
18th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Milan, Italia. 7-11 nov 2015
Solé A, Poveda JL, Girón R, Prados C, De Gracia J, Casado MA
Economic Impact linked to the reduction of exacerbations when a treatment regime with inhaled antibiotics is switched to aztreonam lysine in patients with cystic fibrosis and chronic pulmonary infection caused by Pseudomonas aeruginosa
17th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Amsterdam, Holland. 8-12 nov 2014
Villarrubia R, Oyagüez I, Álvarez MT, Mingot ME, Parra R, Casado MA
Cost analysis of bypassing agent prophylaxis treatment versus on-demand therapy in hemophilia a with inhibitor in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Gros B, Soto J, Casado MA
Future costs inclusion in published economic evaluations: What is the current situation?
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Álvarez-Sabín J, Masjuan J, Torres C, Mar J, Oliva J, González-Rojas N
Health-related quality of life in patients along first year poststroke in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Morote J, Cozar JM, Durán I, Gómez F, León L, Maroto P, Miñana B, Solsona E, Oyagüez I, Casado MA, Roldán C, Gutierrez L, Hechmati G
Cost assessment of metastatic and non-metastatic castration-resistante prostate cancer patient-management in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Torres C, Betoret I, Sabater E, Riera M, Casado MA, Figueras M
Cost-effectiveness analysis of glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease in Spain
16th Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Dublin, Irlanda. 2-6 nov 2013
Ariza-Ariza R, Van Walsem A, Canal C, Roldán C, Betegón L, Oyagüez I, Janssen K